CareLit · DOI-Nachweis · Klinische Neurophysiologie
Intravenous immunoglobulin treatment for patients with primary or secondary progressive Multiple Sclerosis
DOI 10.1055/s-2006-939085
Bibliografische Angaben
Nachweis in CareLit
Autor:innenI Andresen, D Pöhlau, H Przuntek, P Späth
ZeitschriftKlinische Neurophysiologie
Ausgabe03/2006
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Intravenous immunoglobulin (IVIG) has a number of potential effects that may be beneficial in multiple sclerosis (MS): neutralisation of autoantibodies against myelin proteins, down-regulation of T or B cells or pro-inflammatory cytokines, functional blockade of Fc receptors on macrophages and inhibition of complement activation. Objective: To evaluate the reduction of progression, functional improvement…
Zitieren
Zitierempfehlung
I Andresen, D Pöhlau, H Przuntek, P Späth (2006) Intravenous immunoglobulin treatment for patients with primary or secondary progressive Multiple Sclerosis. Klinische Neurophysiologie (03). https://doi.org/10.1055/s-2006-939085
Mit CareLit weiterarbeiten